Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Pharmacol Biochem Behav. 2017 Aug 5;160:55–62. doi: 10.1016/j.pbb.2017.08.002

Figure 1.

Figure 1

A. Ethanol intake during 2 hr DID tests on Days 1–3. Drug groups are shown but did not receive any injections until Day 4. B. Ethanol intake during the first 2 hr and second 2 hr on Day 4. Vehicle, acamprosate (ACA), R-baclofen (BAC) or naltrexone (NTX) was administered ip ½ hr before the DID test. C. Total ethanol intake by each group during the 4 hr DID test on Day 4. Acamposate significantly reduced drinking. D. Blood alcohol level immediately after the Day 4 test.

All groups represent mean ± SE combined data from approximately equal numbers of female and male mice. *p < 0.05.